Andra Ap Fonden Amgen Inc Transaction History

Andra Ap Fonden

$6.89 Billion
Q2 2025

A detailed history of Andra Ap Fonden transactions in Amgen Inc stock. As of the latest transaction made, Andra Ap Fonden holds 11,600 shares of AMGN stock, worth $3.46 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,600

Previous 57,500 79.83%

Holding current value

$3.46 Million

Previous $17.9 Million 81.92%

% of portfolio

0.05%

Previous 0.31%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$262.28 - $309.85 $12 Million - $14.2 Million	-45,900 Reduced 79.83%	11,600 $3.24 Million
Q1 2025 May 13, 2025	BUY	$258.59 - $327.36 $4.42 Million - $5.6 Million	17,100 Added 42.33%	57,500 $17.9 Million
Q4 2024 Feb 07, 2025	BUY	$258.78 - $328.31 $3.21 Million - $4.07 Million	12,400 Added 44.29%	40,400 $10.5 Million
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $4.98 Million - $5.43 Million	-16,100 Reduced 36.51%	28,000 $9.02 Million
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $2.1 Million - $2.55 Million	-8,000 Reduced 15.36%	44,100 $13.8 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $14 Million - $16.9 Million	52,100 New	52,100 $14.8 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $2.23 Million - $2.64 Million	-10,400 Reduced 25.49%	30,400 $6.75 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $1.4 Million - $1.71 Million	-6,200 Reduced 13.19%	40,800 $9.86 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $2.04 Million - $2.59 Million	-8,900 Reduced 15.92%	47,000 $12.3 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $89,784 - $101,260	-400 Reduced 0.71%	55,900 $12.6 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $3.3 Million - $3.67 Million	-14,300 Reduced 20.25%	56,300 $13.7 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $403,313 - $472,530	-1,900 Reduced 2.62%	70,600 $15 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $3.57 Million - $3.96 Million	15,300 Added 26.75%	72,500 $17.7 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $399,438 - $465,480	-1,800 Reduced 3.05%	57,200 $14.2 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $5 Million - $5.95 Million	23,100 Added 64.35%	59,000 $13.6 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $117,325 - $130,475	500 Added 1.41%	35,900 $9.12 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $731,897 - $898,138	-3,700 Reduced 9.46%	35,400 $8.35 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $255,136 - $338,380	1,400 Added 3.71%	39,100 $7.93 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $510,867 - $656,640	-2,700 Reduced 6.68%	37,700 $9.09 Million
Q3 2019 Nov 19, 2019	SELL	$174.11 - $208.62 $1.04 Million - $1.25 Million	-6,000 Reduced 12.93%	40,400 $7.82 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $183,370 - $214,951	-1,100 Reduced 2.32%	46,400 $8.55 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $1.81 Million - $2.04 Million	-10,000 Reduced 17.39%	47,500 $9.02 Million
Q3 2018 Oct 16, 2018	BUY	$185.29 - $208.89 $1.3 Million - $1.46 Million	7,000 Added 13.86%	57,500 $11.9 Million
Q2 2018 Aug 17, 2018	SELL	$166.05 - $186.51 $1.1 Million - $1.23 Million	-6,600 Reduced 11.56%	50,500 $9.32 Million
Q1 2018 Apr 10, 2018	BUY	$169.43 - $198.0 $2.86 Million - $3.35 Million	16,900 Added 42.04%	57,100 $9.73 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $135,032 - $150,872	800 Added 2.03%	40,200 $6.99 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $6.59 Million - $7.53 Million	39,400	39,400 $7.35 Million

Others Institutions Holding AMGN

# of Institutions

3,287

Shares Held

440M

Call Options Held

6.25M

Put Options Held

7.38M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $160B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account